Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus—a multi-centre study

Authors


  • (Trial Registry No; METc 2006/187)

Joop D. Lefrandt. E-mail: j.d.lefrandt@umcg.nl

Abstract

Diabet. Med. 29, 1556–1561 (2012)

Abstract

Aims  Skin autofluorescence is a non-invasive marker of advanced glycation end product accumulation. In a previous study, skin autofluorescence correlated with and predicted micro- and macrovascular complications in Type 2 diabetes in a primary care setting. The present cross-sectional study aims to confirm the association between skin autofluorescence and diabetic complications in patients with Type 2 diabetes in a multi-centre secondary care setting.

Methods  We analysed 563 subjects with Type 2 diabetes mellitus from five Dutch hospitals.

Results  Median age was 64 years, median duration of diabetes 13 years and median HbA1c 58 mmol/mol (7.5%). Sixty-one per cent of patients had microvascular complications (38% nephropathy, 36% retinopathy, 35% neuropathy) and 42% had macrovascular complications. Median UK Prospective Diabetes Study 10-year risk for coronary events was 19%. Median skin autofluorescence was elevated compared with age-matched healthy control subjects: 2.77 (interquartile range 2.39–3.28) vs. 2.46 (2.08–2.84) arbitrary units. Skin autofluorescence was particularly increased in patients with complications: no complications, median 2.56 (2.26–2.90); microvascular complications, 2.79 (2.38–3.29); macrovascular complications, 2.85 (2.41–3.41); both micro- and macrovascular complications, 2.96 (2.56–3.60) arbitrary units, P < 0.001. Logistic regression analysis showed that age, duration of diabetes, renal function, gender, atrial fibrillation and skin autofluorescence were independently associated with macrovascular complications. Multiple regression analysis identified age, smoking, renal function, macrovascular complications and the number of microvascular complications as the determinants of skin autofluorescence.

Conclusions  This study confirms that skin autofluorescence is increased in patients with Type 2 diabetes in a secondary care setting. Skin autofluorescence was associated with macrovascular complications in patients with diabetes and this association was independent of classical risk factors.

Ancillary